TY  - JOUR 
AU  - Instituto Universitario de Biomedicina (IBIOMED)
AU  - Porras, David
AU  - García Mediavilla, María Victoria
AU  - Nistal González, Maria Esther
AU  - Martínez Flórez, Susana
AU  - Pisonero-Vaquero, Sandra
AU  - Jorquera, F.
AU  - Olcoz Goñi, José Luis
AU  - Jover Atienza, Ramiro
AU  - González Gallego, Javier
AU  - Sánchez-Campos, Sonia
AU  - Otros
DA  - 2017/04/04
PY  - 2018
UR  - http://hdl.handle.net/10612/8423
AB  - Gut microbiota is involved in obesity,
metabolic syndrome and nonalcoholic fatty liver disease (NAFLD).
Quercetin may have the ability to modulate the intestinal microbiota
composition, suggesting therapeutic potential in NAFLD. The present
study...
LA  - eng
PB  - Elsevier
KW  - Medicina. Salud
KW  - Biomedicina
KW  - Obesidad
KW  - Quercetina
KW  - Disbiosis
KW  - Ratones
TI  - Protective effect of quercetin treatment on HFD-induced intestinal dysbiosis and barrier dysfunction in an in vivo model of non-alcoholic fatty liver disease
ER  -